During Dr Shaw’s career at the University of Florida in the 1990s, antibodies made for research purposes were licensed to outside companies for sale. Some of these are still today sold by vendors such as
Cell Signaling Technology. EnCor Biotechnology was therefore formed at the end of 1999 initially to market antibody
reagents made in Dr. Shaw's research laboratory at lower prices. In late 2001 EnCor rented lab space at the Sid Martin Biotechnology Incubator, a facility dedicated to commercialization of intellectual property generated in the University of Florida. Following this move the EnCor laboratory produced an increasing number of novel antibodies which were made, characterized, documented, manufactured and subjected to rigorous quality control. The company quickly therefore increased the number of reagents available for sale and soon become profitable and, in 2006, relocated to Gainesville, Florida. subunit NF-L, (
HGNC name
NEFL), which reveals a large neuron. The cells in the above image were also stained in red with an EnCor rabbit antibody to
α-internexin, which in this culture is found in neuronal stem cells. stained with an EnCor mouse monoclonal antibody to NF-L revealed with a brown dye, cell nuclei are revealed with a blue dye. Nuclear rich region at left is the cerebellar granular layer, the region at the right with fewer nuclei is the cerebellar molecular layer. The NF-L antibody binds processes of basket cells, parallel fiber axons, the perikarya of
Purkinje and some smaller neurons and various other fine axons. EnCor has always collaborated with basic scientists and clinicians to produce articles in peer-reviewed scientific publications focused on the examination of various
plasma,
serum and
CSF biomarkers of nervous system damage and degeneration. One of these is the
phosphorylated,
axonal form of the major
neurofilament protein heavy chain protein which has the
HGNC name
NEFH, though is usually referred to as pNF-H in the scientific literature. Two further studies describe novel EnCor assays for
UCHL1 and
alpha-synuclein, two major brain proteins implicated in the development of
Parkinson's and other neurological diseases. In 2022 EnCor, in collaboration with researchers at the University of Florida described a novel class of antibodies to neurofilament light chain with the HGNC name
NEFL, although the protein is usually referred to as NF-L. Surprisingly, one class of these antibodies bind
epitopes hidden in healthy neurons and their processes but which are revealed on degeneration. Another class of antibody to neurofilament NF-L was shown to bind only neurofilaments in healthy neurons and their processes but failed to recognize degenerating and degenerated neurons and processes. The antibodies degeneration specific antibodies have been dubbed "DegenoTag" reagents and should have wide utility for researchers on neurodegeneration. By 2022, the EnCor product line had increased to over 250 items, the antibodies mostly being used for research purposes, with a particular focus on
immunocytochemistry and
western blotting, though many are also utilized for
immunocytochemistry,
immunoprecipitation and
ELISA. Some have become useful for diagnostic
histopathology and for monitoring the levels of protein
biomarkers, of research and potential clinical utility. EnCor supplies reagents to research labs and other reagent companies such as
Abcam,
BioLegend,
Thermo Fisher Scientific,
EMD Millipore, and
Bio-Techne. EnCor is well known for the quality of its cell, tissue and western blotting images, many of which have been made available on
Wikipedia Commons and widely used in books, articles, posters, for teaching, advertising and many other purposes, see . ==Key EnCor Publications==